MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-17-2026
IQVIA Holdings Market Cap 2011-2026 | IQV
As of April 27, 2026 IQVIA Holdings has a market cap of $ 28.1 B
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap IQVIA Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28.3 B | 35.7 B | 44.4 B | 42.5 B | 46.9 B | 34 B | 30.6 B | 26 B | 22.7 B | 11.2 B | 7.48 B | 7.74 B | 5.92 B | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 46.9 B | 5.92 B | 26.4 B |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Diagnostics research industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
221 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
42 B | $ 116.13 | 0.51 % | $ 35.3 B |  USA |
|
Akumin
AKU
|
75.1 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
40.3 M | - | -61.36 % | $ 2.46 M | USA |
 |
Co-Diagnostics
CODX
|
5.85 M | $ 1.64 | -1.8 % | $ 2.18 M | USA |
 |
Aspira Women's Health
AWH
|
45.4 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
5.93 M | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
709 M | $ 25.51 | 4.29 % | $ 709 M | USA |
 |
Chembio Diagnostics
CEMI
|
12.6 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
4.33 M | - | - | $ 9.42 M |  Israel |
 |
CareDx, Inc
CDNA
|
993 M | $ 21.53 | 1.39 % | $ 1.15 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
421 M | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
42.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
57.5 K | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
19.5 B | - | - | $ 19.8 B | USA |
 |
Illumina
ILMN
|
16.4 B | $ 127.88 | - | $ 20.3 B | USA |
 |
Fulgent Genetics
FLGT
|
467 M | $ 15.96 | -2.15 % | $ 483 M | USA |
 |
Global Cord Blood Corporation
CO
|
243 M | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
481 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
1.54 B | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
7.69 B | $ 173.08 | 1.95 % | $ 8.58 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
7.87 B | - | - | $ 10.7 B | USA |
 |
Guardant Health
GH
|
13.4 B | $ 90.12 | 1.36 % | $ 11.3 B | USA |
 |
Lantheus Holdings
LNTH
|
5.12 B | $ 83.88 | -0.53 % | $ 5.66 B | USA |
 |
Medpace Holdings
MEDP
|
13 B | $ 415.61 | 1.23 % | $ 12 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
2.99 M | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
844 M | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
7.34 M | $ 1.91 | -3.29 % | $ 8.45 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
30.8 B | $ 27.57 | 0.35 % | $ 20 B |  Niderland |
 |
Motus GI Holdings
MOTS
|
990 K | - | -34.28 % | $ 263 K | Israel |
 |
Senseonics Holdings
SENS
|
351 M | $ 7.04 | -0.14 % | $ 294 M | USA |
 |
QIAGEN N.V.
QGEN
|
8.52 B | - | - | $ 10.6 B | Niderland |
 |
Neogen Corporation
NEOG
|
1.02 B | $ 9.49 | -0.47 % | $ 2.06 B | USA |
 |
Soleno Therapeutics
SLNO
|
2.08 B | $ 52.73 | 0.01 % | $ 2.68 B | USA |
 |
Biomerica
BMRA
|
7.19 M | $ 2.14 | - | $ 4.92 M | USA |
 |
National Research Corporation
NRC
|
315 M | $ 17.17 | -0.35 % | $ 384 M | USA |
 |
ICON Public Limited Company
ICLR
|
16.6 B | $ 100.45 | -1.68 % | $ 8.29 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
23.9 B | $ 263.57 | -0.06 % | $ 21.9 B | USA |
 |
Thermo Fisher Scientific
TMO
|
196 B | $ 470.21 | 0.14 % | $ 177 B | USA |
 |
Celcuity
CELC
|
5.37 B | $ 124.3 | 2.7 % | $ 5.81 B | USA |
 |
Trinity Biotech plc
TRIB
|
120 M | $ 0.68 | 4.37 % | $ 61.9 M | Irlanda |
 |
OpGen
OPGN
|
9.12 M | - | -16.95 % | $ 1.54 M | USA |
 |
NeoGenomics
NEO
|
1.48 B | $ 8.46 | 1.99 % | $ 1.08 B | USA |
 |
Twist Bioscience Corporation
TWST
|
1.56 B | $ 60.08 | -1.41 % | $ 3.59 B | USA |
 |
Myriad Genetics
MYGN
|
409 M | $ 4.75 | -0.73 % | $ 440 M | USA |
 |
Natera
NTRA
|
5.31 B | $ 206.37 | 1.29 % | $ 20.3 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
23.3 B | $ 197.17 | 0.49 % | $ 21.9 B | USA |
 |
Invitae Corporation
NVTA
|
511 M | - | - | $ 21.2 M | USA |
 |
PerkinElmer
PKI
|
14.1 B | - | -0.91 % | $ 14.7 B | USA |